Pearl Health raises $110M to back independent docs in Medicare

Key Takeaways

• Pearl Health raised $50M in Series C equity from a16z, Viking Global, AlleyCorp, and Ulysses Capital
• A separate $60M debt facility from Trinity Capital brings the round's total capital to $110M
• The company has now raised $125.5M in total equity since its 2020 founding

Pearl Health, a New York-based platform that helps primary care physicians take on Medicare risk without selling their practices, has closed a $50M Series C led by Andreessen Horowitz. Viking Global Investors, AlleyCorp, and Ulysses Capital also participated. Alongside the equity, Trinity Capital committed a $60M debt facility, bringing the round's total new capital to $110M.

The company has now raised $125.5M in reported equity funding since Ankit Patel, Jeff De Flavio, Kevin Ryan, and Michael Kopko founded it in 2020. Six years from launch to Series C is slower than the median SaaS path, but Pearl operates in healthcare, where regulatory complexity and sales cycles stretch timelines.

What does Pearl Health actually do?

Pearl provides the infrastructure for independent primary care doctors to participate in Medicare's ACO REACH program. That program lets physician groups accept financial responsibility for the total cost of caring for a patient panel. If they keep patients healthy and out of the hospital, they share the savings. If costs run over, they absorb part of the loss.

The catch: managing that risk requires analytics, care coordination tools, administrative staff, and actuarial know-how that a typical five-doctor practice cannot build alone. Large health systems and private-equity-backed groups have scale. Solo and small-group physicians do not. Pearl fills the gap. It handles data integration, risk stratification, quality reporting, and the back-office work so doctors can focus on patients.

The company reportedly works with over 10,000 primary care physicians. That scale matters because ACO REACH performance is judged relative to benchmarks. More data on more patients makes predictions more accurate and interventions more targeted.

Why a16z led the round

Andreessen Horowitz has bet heavily on healthcare software, from clinical trial automation to electronic health records. Value-based care sits at the intersection of two trends the firm tracks: AI-powered data analytics and the shift from fee-for-service to outcomes-based reimbursement. Medicare's spending hit $839 billion in FY2022, and the Centers for Medicare & Medicaid Services wants most of that flowing through value-based arrangements by the end of the decade.

Pearl's co-founder Kevin Ryan has a track record that draws investor attention on its own. He founded DoubleClick, Gilt Groupe, MongoDB, and Business Insider. AlleyCorp, Ryan's venture firm, has backed Pearl from the early days, and this follow-on signals continued conviction.

Why the debt matters

Equity tells you investors believe in the business. Debt tells you lenders believe in the cash flows. Trinity Capital's $60M facility suggests Pearl has predictable revenue, likely a per-physician SaaS fee plus a share of the savings it helps generate. Debt is cheaper than equity when revenue visibility is high, and it avoids further dilution for founders and early investors.

For a six-year-old company, combining growth equity with venture debt signals a transition toward capital efficiency. That matters in a 2026 funding environment where investors scrutinize burn multiples more than they did in 2021.

Competitive landscape

Pearl is not alone. Aledade, which also enables independent physicians in value-based care, raised $260M in 2023 and has crossed $1B in total funding. Privia Health trades publicly with a market cap above $3 billion. Oak Street Health, acquired by CVS for $10.6 billion in 2023, took a different route by employing physicians directly.

Pearl's pitch is that it preserves physician independence. Doctors keep ownership of their practices; Pearl provides the platform. For founders thinking about market positioning, this is a classic wedge: serve a segment that incumbents overlook or undervalue, then expand.

What Pearl might do with the capital

The company has not detailed specific plans, but the pattern is predictable. More physician groups, more geographies, deeper analytics. AI-driven risk models that identify which patients need outreach before they end up in the ER. Possibly acquisitions of smaller enablement vendors. The $60M debt facility could also fund working-capital needs tied to the timing of CMS reconciliation payments.

Founders building in healthcare should note the timeline. Pearl took six years to reach this stage. Healthcare sales are slow. Regulatory compliance is expensive. Patience and capital reserves matter more than speed.

Frequently Asked Questions

What is Pearl Health?

Pearl Health is a healthcare technology company that enables independent primary care physicians to participate in Medicare's value-based care programs by providing analytics, care coordination tools, and administrative support.

Who are Pearl Health's investors?

Key investors include Andreessen Horowitz (Series C lead), Viking Global Investors, AlleyCorp, and Ulysses Capital. Trinity Capital provided a $60M debt facility.

How much has Pearl Health raised in total?

Pearl Health has raised $125.5M in reported equity funding, plus a $60M debt facility announced with this round.

What is value-based care?

Value-based care is a reimbursement model where providers are paid based on patient health outcomes rather than the volume of services delivered. Physicians share in savings when they keep patients healthy.

Who founded Pearl Health?

Pearl Health was founded in 2020 by Ankit Patel, Jeff De Flavio, Kevin Ryan, and Michael Kopko.

Source: AlleyWatch